Clinical Trials Logo

Filter by:
NCT ID: NCT00773240 Completed - Clinical trials for Grass Pollen Allergy

A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The study assess the pharmacodynamic effect and the tolerability of Grazax treatment initiated in the grass pollen season in subjects with seasonal grass pollen induced rhinoconjunctivitis

NCT ID: NCT00772733 Completed - COPD Clinical Trials

A Project Ensuring Quality and Cooperation in the Chronic Obstructive Pulmonary Disease (COPD) Treatment

KOSMOS
Start date: October 2008
Phase: N/A
Study type: Observational

The purpose of this study is to ensure the quality of the COPD treatment in primary care by implementing planned follow-up visits, where the disease condition is evaluated and optimised in accordance with the national COPD recommendations. If relevant the general practitioner (GP) will refer patients to COPD rehabilitation conducted by relevant municipality rehabilitation teams. Secondarily the purpose is to improve collaboration and communication between the local hospital pulmonologist, GPs and the municipality rehabilitation team

NCT ID: NCT00772538 Completed - Asthma Clinical Trials

Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)

Start date: October 2008
Phase: Phase 3
Study type: Interventional

The trial is a randomised, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of 5 µg tiotropium over a 48-week treatment period as compared to placebo. Tiotropium inhalation solution delivered by the Respimat® inhaler will be examined as add-on controller therapy on top of usual care in patients with severe persistent asthma. The primary objective of each trial is to evaluate the long term efficacy of tiotropium over placebo on top of usual care in patients with severe persistent asthma as determined by pulmonary function testing, effects on asthma exacerbations, effects on quality of life, on asthma control and health care resource utilisation. The secondary objective of each trial is to compare the long term safety of tiotropium with placebo in this patient population.

NCT ID: NCT00772226 Completed - Pain Clinical Trials

The Use of Music as Pain Therapy in Patients Undergoing Laparoscopic Cholecystectomy in a Day Care Unit

Start date: September 2008
Phase: Phase 3
Study type: Interventional

The study is undertaken to investigate whether relaxing music therapy before, during and after laparoscopic cholecystectomy has any effect on pain, PONV or fatigue and level of stress as measured by Cortisol and C reactive protein. Patients will be scored according to those endpoints 1 and 3 hours after surgery and on day 1 and 7 post-OP.

NCT ID: NCT00771966 Completed - Prostate Cancer Clinical Trials

Radical Prostatectomy and Perioperative Fluid Therapy

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The optimal amount of fluid a patient need under surgery is not clear. Both to much and to little fluid can damage the organ functions. A strategy called "Goal directed therapy", where the fluid amount a patient need is guided by the stroke volume, has shown to minimize post-operative nausea and vomiting. The investigators intend to investigate if patients treated after these standards, has a better outcome then patients treated after normal regimes, regarding post-operative orthostatic-intolerance.

NCT ID: NCT00771940 Completed - Healthy Controls Clinical Trials

Peripheral Metabolic Effects of Ghrelin

Start date: October 2008
Phase: Phase 1
Study type: Interventional

The aim of this study is to investigate putative peripheral effects of ghrelin on glucose and lipid metabolism in healthy men. Eight subjects will be enrolled. The hypothesis is that ghrelin infusion causes insulin resistance and lipolysis.

NCT ID: NCT00771459 Completed - Pain, Postoperative Clinical Trials

Local Infiltration Analgesia in Major Spine Surgery With Ropivacaine Versus Placebo

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine whether local infiltration analgesia (LIA) with Ropivacaine and adrenaline is effective in the treatment of postoperative pain after major spine surgery.

NCT ID: NCT00770939 Completed - Clinical trials for Diabetic Foot Ulcers

Evaluation of the Effect of Vivostat Platelet Rich Fibrin(PRF) in the Treatment of Diabetic Foot Ulcers

Start date: July 2008
Phase: Phase 4
Study type: Interventional

Diabetic foot ulcers are a challenge to health care professionals because there are only few effective topical therapeutic interventions. Growth factor treatment has shown to be beneficial for healing of diabetic foot ulcers in conjunction with extensive surgical debridement. Autologues platelet releasate which contains platelet derived growth factor appears to be more effective than standard therapy in case studies. This protocol will evaluate the healing effect of Vivostat PRF treatment of non-eschemic foot ulcers to identify responders and to enable sample size calculation for a subsequent pivotal trial.

NCT ID: NCT00769054 Completed - Vaginal Prolapse Clinical Trials

Local Infiltration Analgesia With Ropivacaine in Posterior Vaginal Wall Prolapse:a Randomized, Double-Blind Study

Start date: October 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare systematic local infiltration with ropivacaine or placebo in patients undergoing repair of posterior vaginal wall prolapse. The hypothesis is that LIA technique is opioid-sparing and a better postoperative treatment.

NCT ID: NCT00768547 Completed - Hematologic Tests Clinical Trials

Risk Stratification in Acutely Admitted Medical Patients

Start date: August 2008
Phase: N/A
Study type: Observational

The study has three main parts. 1. To see if we can develop a riskstratification tool that can be used to asses the risk for acutely admitted medical patients for inhospital death, admission to the ICU and death within 30 days of release. 2. To test existing tool as in 1. 3. To clarify if it is most reasonable to let the admitting doctor order blood test by clinical judgment or be using a predefined list of tests.